A restrictive practice (RP) is defined as a practice or intervention that has the effect of
restricting the rights or freedom of movement of a person, and includes physical …

Background Adults with intellectual disability (ID) are prescribed high levels of medication,
with polypharmacy and psychotropic polypharmacy common. However, reported rates vary …

Abstract Purpose of Review The purpose of this paper is to provide a brief review of the
patterns of psychotropic medication use in individuals with intellectual and developmental …

Purpose People with intellectual disabilities (ID) suffer multimorbidity, polypharmacy and
excess mortality at a younger age than general population. Those with ID and epilepsy are …

Background Research indicates that adults with intellectual disabilities are living longer.
However, there is limited research on how this affects health and care needs. Objective The …

Applied behavioral pharmacology explores how drugs may influence problem behavior in
persons with intellectual and developmental disability (IDD). A comprehensive review was …

Background Adults and older people with intellectual disabilities (ID) frequently receive anti-
cholinergic drugs in chronic use, but no studies in Italy to date have investigated cumulative …

For~ 80 drugs, widely recognized pharmacogenetics dosing guidelines are available.
However, the use of these guidelines in clinical practice remains limited as only a fraction of …

Multimorbidity, defined as having two or more chronic health conditions, is associated with
elevated polypharmacy and mortality. Autism spectrum disorder is a whole-body chronic …

Background Psychotropic medication is frequently administered to people with intellectual
disability with mental health and/or behavioural problems, instead of other non …